Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...
New data shows that men are still more likely than women to be diagnosed with diabetes in the U.S., rates of the disease have ...
A recent study that found there has been a massive increase in type 2 diabetes cases worldwide since 1990 is an indication that the market for GLP-1 drugs could likely be a lot bigger. Based on data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback